Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06444555
Other study ID # ONZ-2024-0038
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 28, 2024
Est. completion date July 1, 2024

Study information

Verified date June 2024
Source University Ghent
Contact Carl Lachat, Prof
Phone 003292649377
Email carl.lachat@ugent.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adolescents' diets are key to breaking the intergenerational cycle of malnutrition. This study will guide policies and programs on the adequacy, acceptability, and feasibility of implementing balanced energy protein and multiple micronutrient supplementations to fill nutrient gaps in adolescent girls. Using a trial, the study will assess dietary intake and nutrient gaps, acceptability of balanced energy protein and multiple micronutrient supplementations. In addition to the trial, the study will the assess willingness to pay for the supplements and the most effective delivery platform and model to reach vulnerable adolescent girls. The most effective delivery platform and model to reach vulnerable adolescent girls cost-effectively will also be assessed through interviews with (inter)national experts, producers, and the donor community.


Description:

In low- and middle-income countries, it is estimated that each year, 21 million adolescent girls become mothers. Infants of adolescent mothers are at increased risk of delivering babies preterm, with low birth weight or length. Targeting nutrition interventions to improve adolescent girls' diet and nutrition is crucial to breaking the intergenerational cycle of poor growth and development. There is a specific need to assess how a balanced energy protein (BEP) and multiple micronutrient (MMN) supplement interventions can be tailored to adolescent girls and women of reproductive age. This study aims to assess the adequacy, acceptability, and feasibility of implementing nutritional supplementations to fill nutrient gaps in adolescent girls in resource-limited settings. A trial will specifically: 1. assess the short-term acceptability of BEP and MMN supplements 2. assess how nutrition supplements increase nutrient adequacy of diets adolescent girls in resources-limited settings; Using a qualitative component, the study explores the food agency of adolescents and the most effective delivery platform to reach vulnerable adolescent girls cost-effectively. The overall aim is to guide policies and programs on new formulations of nutritional supplements for adolescent girls in resource-limited settings.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date July 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 19 Years
Eligibility Eligibility criteria are all based on self-reported information Inclusion criteria: - Non-pregnant and non-lactating women - Without any known chronic illness or acute illness affecting appetite - Permanent residents of the study area Exclusion criteria: - Being allergic to peanuts - Eating disorders or dietary restrictions

Study Design


Related Conditions & MeSH terms

  • Nutrition Deficiency Due to Insufficient Food

Intervention

Dietary Supplement:
BEP supplement
The BEP supplement used in Burkina Faso is a fortified medium-quantity lipid-based nutrient supplement called Plumpy'Doz. The product is a peanut and milk-based ready-to-use nutritional formulation produced by Nutriset. A peanut-based BEP formulation with a trademark Plumpy'Sup produced by Hilina Enriched Foods PLC will be used in Ethiopia.
Multiple Micronutrient supplement
The MMN formulation is based on the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP). The formulation contains 15 minerals and vitamins and is administered as a tablet.

Locations

Country Name City State
Burkina Faso Agence de Formation, de Recherche et d'Expertise en Santé pour l'Afrique (AFRICSanté) Bobo-Dioulasso
Ethiopia Addis Continental Institute of Public Health Addis Ababa

Sponsors (5)

Lead Sponsor Collaborator
University Ghent Addis Continental Institute of Public Health, AfricSanté, Burkina Faso, Bill and Melinda Gates Foundation, Institut de Recherche en Sciences de la Sante, Burkina Faso

Countries where clinical trial is conducted

Burkina Faso,  Ethiopia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acceptability of the supplement Acceptability to the nutritional supplements, as measured using a 9-item scale (1 "Dislike extremely" up to 9 "Like extremely") Day 8 (after 7 days of consumption)
Primary Nutritional adequacy Mean nutrient adequacy ratio of adolescent diets, using 24 h recall Day 8 (after 7 days of consumption)
Secondary Willingness to pay for the supplement Mean household head's willingness to pay values elicited through their bids Day 8 (after 7 days of consumption)
Secondary Reported consumption of the supplement Percent of the recommended nutritional supplement consumed during the intervention period, self-reported Day 8 (average of 7-day intervention)
Secondary Substitution of food and nutrient intake Substitution of food and nutrition intake at group level, using 24 h recall Day 8 (after 7 days of consumption)
Secondary Nutrient intake Mean energy, macronutrient and micronutrient intake between the BEP and MMN group, using 24 h recall Day 8 (after 7 days of consumption)
See also
  Status Clinical Trial Phase
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT04845230 - Fresh RX: NHS 2020 N/A
Completed NCT05347888 - How Well do we Feed the Critically Ill Patients